Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

CFS 2011 /
Pomegranate extract for prostate cancer patients

20th May 2011

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 24.11.11
Views: 3574
Rating:

Prof Michael Carducci - Johns Hopkins Medical Institutions, Baltimore, USA

Prof Michael Carducci speaks to ecancer.tv about a trial looking at the use of pomegranate extract in prostate cancer patients with post treatment increases in PSA (prostate-specific antigen). Patients were assessed to see how quickly PSA level doubled and this was compared to the expected duration. Although this study was not placebo controlled, time until PSA doubled increased by six to seven months in patients taking the extract. Quantity of pomegranate extract did not affect efficacy and Prof Carducci explains that although this extract has not been approved medicinal use there is no associated danger and it could potential have beneficial effects.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence